75690 Federal Register / Vol. 75, No. 233 / Monday, December 6, 2010 / Notices 

for eight committee members. The 

NACNEP advises and makes 

recommendations to the Secretary and 

Congress on policy matters arising in 

the administration of Title VIII, 

including the range of issues relating to 

the nurse workforce, nursing education 

and nursing practice improvement. The 

Advisory Council may make specific 

recommendations to the Secretary and 

Congress regarding programs 

administered by the Division of 

Nursing, Bureau of Health Professions, 

Health Resources and Services 

Administration. The Advisory Council 

provides advice to the Secretary and 

Congress in preparation of general 

regulations and with respect to policy 

matters in the administration of this 

Title including the range of issues 

relating to nurse supply, education, and 

practice improvement. The Advisory 

Council shall annually prepare and 

submit to the Secretary, the Committee 

on Health, Education, Labor, and 

Pensions of the Senate and the 

Committee on Energy and Commerce of 

the House of Representatives, a report 

describing the activities of the Advisory 

Council including its findings and 

recommendations. 

The Department of Health and Human 

Services is requesting a total of eight 

nominations for members of the 

NACNEP who represent any of the 

following groups: Full-time students 

representing various levels of education 

in schools of nursing; the general 

public; practicing professional nurses; 

leading authorities in the various fields 

of nursing, higher secondary education 

and associate degree schools of nursing; 

and representatives of advanced 

education nursing groups (such as nurse 

practitioners, nurse midwives, and 

nurse anesthetists), hospitals, and other 

institutions and organizations which 

provide nursing services. The majority 

of members of the fully constituted 

Council shall be nurses. 

The Department is legally required to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the functions to be 

performed by the advisory committee. 

Every effort is made to ensure that the 

views of women, all ethnic and racial 

groups, and people with disabilities are 

represented on all HHS Federal advisory 

committees and, therefore the 

Department encourages nominations of 

qualified candidates from these groups. 

The Department also encourages 

geographic diversity in Council 

composition. Appointment to this 

Council shall be made without 

discrimination on the basis of age, race, 

ethnicity, gender, sexual orientations, 

disability, culture, religion or 

socioeconomic status. 

Interested persons may nominate one 

or more qualified persons for 

membership. Self-nominations are also 

accepted. Nominations must be 

typewritten. The following information 

should be included in the package of 

materials submitted for each individual 

being nominated: (1) A letter of 

nomination that clearly states the name 

and affiliation of the nominee, the basis 

for the nomination (i.e., specific 

attributes that qualify the nominee for 

services in this capacity as described 

above), a statement that the nominee is 

willing to serve as a member of the 

NACNEP and appears to have no 

conflict of interest that would preclude 

this Council membership. Potential 

candidates will be asked to provide 

detailed information concerning such 

matters as financial holdings, 

consultancies, research grants, and/or 

contracts to permit an evaluation of 

possible sources of conflicts of interest; 

and (2) the nominator’s name, address 

and daytime telephone number; the 

home/or work address, and telephone 

number; and finally, the e-mail address 

of the individual being nominated. 

HRSA requests inclusion of a current 

copy of the nominee’s curriculum vitae 

and a statement of interest from the 

nominee which demonstrates 

experience working with or interest in 

Title VIII nursing programs; expertise in 

the field (if applying as a nursing 

candidate) or understanding of nursing 

issues (if applying as a general public 

candidate); and a personal desire to 

participate on a National Advisory 

Council. Members will receive a stipend 

for each day (including travel time) 

during which they are in attendance at 

official meetings of the Council, as well 

as per diem and travel expenses as 

authorized by section 5 U.S.C. 5703 for 

persons employed intermittently in 

government service. Qualified 

candidates will be invited to serve a 

four-year term. 

Dated: November 30, 2010. 

Robert Hendricks, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–30445 Filed 12–3–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Cancer Immunotherapy. 

Date: December 13, 2010. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892. 301–435– 

1211. quadris@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 29, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30458 Filed 12–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Cancer Institute Clinical Trials 


jdjones on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 233 / Monday, December 6, 2010 / Notices 75691 

and Translational Research Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials and Translational 

Research Advisory Committee. 

Date: December 15, 2010. 

Time: 9 a.m. to 4 p.m. 

Agenda: Strategic Discussion of NCI’s 

Clinical and Translational Research 

Programs. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 6th 

Floor Conference Room, Bethesda, MD 

20892. 

Contact Person: Sheila A. Prindiville, MD, 

MPH, Director, Coordinating Center for 

Clinical Trials, Office of the Director, 

National Cancer Institute, National Institutes 

of Health, 6120 Executive Blvd., 3rd Floor 

Suite, Bethesda, MD 20892. 301–451–5048. 

prindivs@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting date due to 

scheduling conflicts. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: November 29, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30456 Filed 12–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Fellowship: 

Cell Biology Specials. 

Date: December 10, 2010. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Alessandra M. Bini, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892. 301–435– 

1024. binia@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Epidemiology and Genetics of 

Cancer. 

Date: December 14, 2010. 

Time: 11:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Fungai Chanetsa, MPH, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892. 301–408– 

9436. fungai.chanetsa@nih.hhs.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 29, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30455 Filed 12–3–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Notice of Cancellation of Customs 

Broker License 

AGENCY: U.S. Customs and Border 

Protection, U.S. Department of 

Homeland Security. 

ACTION: General notice. 

SUMMARY: Pursuant to section 641 of the 

Tariff Act of 1930, as amended, (19 

U.S.C. 1641) and the U.S. Customs and 

Border Protection regulations (19 CFR 

111.45), the following Customs broker 

license and all associated permits are 

revoked with prejudice. 

Name License 

No. 

Issuing 

port 

Foreign Cargo Customs Brokers, Inc.15965 New York 

Dated: November 29, 2010. 

Daniel Baldwin, 

Assistant Commissioner, Office of 

International Trade. 

[FR Doc. 2010–30427 Filed 12–3–10; 8:45 am] 

BILLING CODE 9111–14–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5376–N–113] 

Notice of Submission of Proposed 

Information Collection to OMB; Notice 

of Proposed Information Collection for 

Public Comment; Mortgage Insurance 

for Cooperative and Condominium 

Housing 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice of proposed information 

collection. 

SUMMARY: The proposed information 

collection requirement described below 

has been submitted to the Office of 

Management and Budget (OMB) for 

emergency review and approval, as 

required by the Paperwork Reduction 

Act. The Department is soliciting public 

comments on the subject proposal. 

Project information is analyzed to 

determine whether a cooperative or 


jdjones on DSK8KYBLC1PROD with NOTICES